FDA Inspection 857686 — Merck Serono SA

Merck Serono SA — FEI 3002807447

The FDA completed an inspection of Merck Serono SA on November 12, 2013 in Aubonne. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 12, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aubonne (Switzerland)